Morning Briefing
Summaries of health policy coverage from major news organizations
Concerns Raised About Popular Blood Pressure, Diabetes Drugs
The Wall Street Journal reports that a senior FDA regulator is seeking stronger warnings about a class of blood pressure drugs that may be linked to higher cancer rates. Meanwhile, The New York Times details how a doctor hired by Merck to test a diabetes drug in rats found a possible link to pancreatic cancer, a discovery that turned the doctor into a crusader.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
